Monday, January 18, 2021
Studies
Neurological
Study Shows NAD+ Supplementation Protects Eye Cells Following Retinal Detachment
Nicotinamide mononucleotide (NMN) improved photoreceptor cell survival by increasing cellular health-promoting and antioxidant enzyme levels.
Neurological
NMN May Improve the Brain-Associated Blood Vessel Cell Response to Stress
NMN treatment improves brain associated blood vessel cell survival and protects against harmful stress in metabolic disorders like diabetes.
Neurological
Supplementing NAD+ Preserves Neurons and Memory Formation in Rats with Hypoglycemia
Research indicates nicotinamide mononucleotide (NMN) supplementation may prevent cognitive impairment in diabetes patients.
Neurological
Neuroscientists Revive Memory Deficits and Brain Cell Loss in Diabetic Rats
Nicotinamide mononucleotide (NMN) intervention protects neurons and memory from diabetes-induced brain degeneration in rats.